BuniaOver 4,500 cases, and the stockpiled vaccine targets the wrong species.
Ervebo protects against Zaire ebolavirus, not the Bundibugyo strain now spreading fastest on record.
The WHO is negotiating a Phase 3 trial randomizing contacts of confirmed cases between Ervebo and placebo.
Oxford and Moderna’s Bundibugyo-specific candidates could join the trial if September safety data hold.
Sources: STAT